Insulin resistance doesn’t show up on a standard blood panel, so measuring it requires either specialized testing or combining a few routine lab values. The gold standard is a research procedure called the hyperinsulinemic-euglycemic clamp, but it’s impractical for everyday use. In real-world settings, most people rely on calculated scores from fasting blood draws, lipid ratios, or simple physical measurements that correlate surprisingly well with more complex tests.
The Gold Standard: The Clamp Test
The hyperinsulinemic-euglycemic clamp is the most accurate way to measure insulin resistance, but it’s almost exclusively used in research. During the procedure, a continuous insulin infusion is delivered intravenously while glucose is simultaneously dripped in at whatever rate keeps blood sugar stable. The amount of glucose your body needs to maintain that steady state reveals how sensitive your cells are to insulin. If you need a lot of glucose infused, your cells are responding well. If you need very little, your cells are resisting insulin’s signal.
The result is expressed as a glucose disposal rate. A rate below about 4.9 mg per kilogram per minute (when adjusted for body weight) indicates insulin resistance. Researchers published in Diabetes Care have also established cutoffs adjusted for fat-free mass, landing around 7.3 mg per kilogram of lean mass per minute. These numbers are useful benchmarks for scientists, but you’ll never encounter them in a doctor’s office. The test takes several hours, requires IV lines and constant monitoring, and costs thousands of dollars.
HOMA-IR: The Most Common Clinical Test
The Homeostatic Model Assessment for Insulin Resistance, or HOMA-IR, is the workhorse of insulin resistance testing. It uses two values from a single fasting blood draw: your fasting glucose and your fasting insulin. The formula multiplies fasting insulin (in microunits per milliliter) by fasting glucose (in millimoles per liter), then divides by 22.5. Many online calculators handle the math for you.
There’s no single universally accepted cutoff, which can be confusing when you’re trying to interpret your result. In U.S. clinical and research settings, values between 2.0 and 3.0 are commonly used as thresholds. The National Health and Nutrition Examination Survey (NHANES) uses 2.5 or higher to indicate insulin resistance. For context, a large study of U.S. adults without diabetes found a median HOMA-IR of 2.2 and a mean of 2.8. In adolescents, normal-weight individuals averaged 2.3, while those with obesity averaged 4.9.
If you’re of Asian descent, the thresholds tend to be lower, typically ranging from 1.4 to 2.5. This is important because insulin resistance can develop at lower body weights in Asian populations, and applying a Western cutoff of 2.5 could miss early problems.
An updated version called HOMA2 improves on the original formula by accounting for several biological factors the simpler equation ignores: the way the liver adjusts its glucose output, differences between how peripheral tissues and the liver respond to insulin, and the fact that some insulin assays pick up proinsulin (an insulin precursor) alongside actual insulin. HOMA2 also handles high blood sugar levels better by factoring in glucose lost through the kidneys. If your doctor orders HOMA testing, it’s worth asking which version they use, though both give clinically useful results.
Fasting Insulin Alone
A fasting insulin level is the simplest single test you can request. Standard laboratory reference ranges consider anything under 25 μIU/mL “normal,” but that ceiling is set to catch overt diabetes rather than early metabolic dysfunction. By the time your fasting insulin reaches 20 or 24, your pancreas has likely been working harder than it should for years.
Clinicians focused on metabolic health often use a tighter target. Values between roughly 2.6 and 5 μIU/mL are considered optimal for long-term metabolic function. This doesn’t mean a fasting insulin of 8 signals a crisis, but a result in the teens or higher suggests your body is producing extra insulin to keep blood sugar in range, which is the hallmark of insulin resistance before glucose levels ever become abnormal. Fasting insulin is inexpensive and widely available, making it a practical first step.
The Triglyceride-to-HDL Ratio
If you already have a standard lipid panel, you can calculate a rough proxy for insulin resistance without any additional testing. Divide your triglycerides by your HDL cholesterol (both in mg/dL). A ratio of 3.0 or higher is associated with insulin resistance in people with a BMI of 25 or above.
This marker has a significant limitation: it performs poorly in African Americans. Research published in Archives of Internal Medicine found that the triglyceride-to-HDL ratio does not reliably predict insulin resistance in Black individuals, likely because of differences in how triglyceride-rich lipoproteins are metabolized across ethnic groups. If you’re African American, HOMA-IR or fasting insulin will give you more reliable information.
The LP-IR Score
A newer option is the Lipoprotein Insulin Resistance score, which uses a specialized blood test called NMR spectroscopy (sometimes ordered as an “NMR LipoProfile”). Rather than looking at standard cholesterol numbers, this test measures the actual sizes and concentrations of lipoprotein particles. Six specific measurements are weighted and combined: the size and concentration of large VLDL particles (which carry the heaviest weight in the score), the size and concentration of HDL particles, and the size and concentration of small LDL particles.
The result falls on a scale from 0 to 100, where 0 means highly insulin sensitive and 100 means highly insulin resistant. The advantage is that it captures metabolic changes that standard lipid panels miss entirely. The downside is that NMR testing isn’t part of routine bloodwork and may not be covered by insurance, though some direct-to-consumer lab services offer it for under $100.
QUICKI: Another Fasting Blood Test
The Quantitative Insulin Sensitivity Check Index uses the same fasting glucose and fasting insulin values as HOMA-IR but runs them through a logarithmic formula. The calculation is 1 divided by the sum of the log of fasting insulin plus the log of fasting glucose (with insulin in microunits per milliliter and glucose in milligrams per deciliter).
In validation studies, nonobese subjects averaged a QUICKI value of about 0.382, obese subjects averaged 0.331, and people with diabetes averaged 0.304. Lower numbers indicate greater insulin resistance. QUICKI correlates well with the clamp test and can be more accurate than HOMA-IR in certain populations, but it’s used far less often in routine clinical practice.
Physical Measurements That Predict Resistance
You don’t always need blood work to get a meaningful signal. Your waist-to-height ratio is a surprisingly strong predictor of insulin resistance because it captures visceral fat, the metabolically active fat stored around your organs that drives inflammation and disrupts insulin signaling. To calculate it, measure your waist at the navel in the same units as your height, then divide waist by height.
A general threshold of 0.5 is widely used: if your waist measurement is more than half your height, your risk of metabolic problems increases substantially. Research in women with polycystic ovary syndrome (a condition closely linked to insulin resistance) found an optimal cutoff of 0.519. This measurement takes 30 seconds with a tape measure and costs nothing, making it a useful screening tool before pursuing lab work.
Acanthosis nigricans, dark velvety patches of skin that typically appear on the neck, armpits, or groin, is another physical sign. It results from excess insulin stimulating skin cell growth and is specific enough that the American Diabetes Association lists it as a reason to screen for metabolic problems in both adults and children.
Which Test Should You Actually Get
For most people, the practical approach is to request a fasting insulin level alongside your regular fasting glucose. Together, these two numbers let you or your doctor calculate HOMA-IR, QUICKI, or simply evaluate the insulin level on its own. The total cost is typically modest since fasting glucose is already part of a basic metabolic panel and fasting insulin is a single add-on test.
If your standard lipid panel is already available, check your triglyceride-to-HDL ratio as well (keeping in mind the ethnic limitations). For a deeper look, an NMR lipoprotein panel with an LP-IR score provides the most nuanced picture short of a clamp test. And before any lab work at all, measure your waist-to-height ratio. If it’s above 0.5, that alone is a reason to investigate further with blood tests.
The ADA doesn’t recommend testing for insulin resistance as a standalone diagnosis. Instead, it uses insulin resistance as a risk factor that triggers screening for prediabetes and diabetes. Testing is recommended for adults with a BMI of 25 or higher (23 or higher for those of Asian descent) who also have conditions associated with insulin resistance, such as significant obesity, fatty liver disease, high blood pressure, abnormal cholesterol, or polycystic ovary syndrome. For children, screening is recommended when they’re above the 85th percentile for weight and have additional risk factors like acanthosis nigricans or a family history of type 2 diabetes.